MedTrace Logo

The Evaluation of the Safety and Effectiveness of ANIMERS Chiara LA and JUVÉDERM VOLUMA® for Aging Mid-Face

NCT04622085 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-10-19

No results posted yet for this study

Summary

This study is to evaluate the safety and effectiveness for the correction of aging mid-face of treatment group compared with the active control group.

Conditions

  • Dermal Filler
  • Hyaluronic Acid
  • Lidocaine
  • Aging Mid-Face

Interventions

DEVICE

ANIMERS Chiara LA

20mg/SciVision Biotech Inc.

DEVICE

JUVÉDERM VOLUMA®

20mg/Allergan, Inc.

Sponsors & Collaborators

  • SciVision Biotech Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-06
Primary Completion
2021-11-04
Completion
2023-05-09

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04622085 on ClinicalTrials.gov